title: Effect of Helicobacter pylori on delay in ulcer healing induced by aspirin in rats.
abstract: Helicobacter pylori and nonsteroidal anti-inflammatory drugs (NSAIDs) are major pathogenic factors in peptic ulcer disease but whether these two factors exert synergistic or antagonistic effects on ulcer healing has been a subject of controversy. We compared the effect of aspirin alone with that of aspirin combined with H. pylori on gastric acid secretion and healing of acetic acid gastric ulcers in rats. The H. pylori colonization of gastric mucosa was determined by viable H. pylori culture, histology and assessment of bacterial DNA using polymerase chain reaction (PCR). The area of ulcers, gastric blood flow, mucosal generation of prostaglandin E(2) and plasma gastrin levels and expression of cyclooxygenase-1, cyclooxygenase-2 and growth factors was determined. Aspirin delayed significantly the healing of chronic gastric ulcers, decreased the gastric blood flow at the ulcer margin and gastric mucosal prostaglandin E(2) generation being without significant influence on gastric acid output. H. pylori acquisition that produced moderate gastric inflammation at the ulcer margin delayed significantly the healing of gastric ulcers, decreased significantly both the gastric blood flow at the ulcer margin and the gastric secretion while raising significantly the gastric mucosal prostaglandin E(2) generation and plasma gastrin levels. H. pylori infection attenuated the aspirin-induced inhibition of ulcer healing and accompanying fall in the gastric blood flow. Both aspirin and H. pylori up-regulated significantly cyclooxygenase-2 messenger RNA (mRNA) and protein but not that of cyclooxygenase-1 at the ulcer margin. Aspirin reduced significantly the transforming growth factor alpha- and vascular endothelial growth factor mRNAs, but these effects were significantly attenuated by H. pylori. We conclude that H. pylori antagonizes, in part, aspirin-induced delay of ulcer healing due to suppression of acid secretion, the enhancement in prostaglandin E(2) possibly derived from cyclooxygenase-2 and the overexpression of transforming growth factor alpha and vascular endothelial growth factor in the ulcer area.
authors.affiliation: First Department of Medicine, University Erlangen-Nuremberg, Erlangen, Germany.
authors.forename: Peter C
authors.initials: PC
authors.lastname: Konturek
authors.forename: Tomasz
authors.initials: T
authors.lastname: Brzozowski
authors.forename: Slawomir
authors.initials: S
authors.lastname: Kwiecień
authors.forename: Danuta
authors.initials: D
authors.lastname: Drozdowicz
authors.forename: Igor A
authors.initials: IA
authors.lastname: Harsch
authors.forename: Holger
authors.initials: H
authors.lastname: Meixner
authors.forename: Jerzy
authors.initials: J
authors.lastname: Stachura
authors.forename: Eckhart G
authors.initials: EG
authors.lastname: Hahn
authors.forename: Stanislaw J
authors.initials: SJ
authors.lastname: Konturek
mesh_terms: D000818:Animals; D001241:Aspirin / Q000633:toxicity*; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2; D005744:Gastric Acid / Q000378:metabolism; D015870:Gene Expression / Q000187:drug effects / Q000502:physiology; D016480:Helicobacter pylori; D007527:Isoenzymes / Q000096:biosynthesis; D008297:Male; D008565:Membrane Proteins; D011451:Prostaglandin-Endoperoxide Synthases / Q000096:biosynthesis; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D017208:Rats, Wistar; D013276:Stomach Ulcer / Q000139:chemically induced / Q000382:microbiology* / Q000473:pathology*; D014945:Wound Healing / Q000187:drug effects* / Q000502:physiology
chemical_list: D007527:Isoenzymes; D008565:Membrane Proteins; D012333:RNA, Messenger; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2; D011451:Prostaglandin-Endoperoxide Synthases; C496513:Ptgs1 protein, rat; D001241:Aspirin